Study to Compare TP-434 and Ertapenem in Community-acquired Complicated Intra-abdominal Infections

Mise à jour : Il y a 4 ans
Référence : NCT01265784

Femme et Homme

Extrait

This is a Phase 2, randomized, double-blind, double-dummy, multicenter, prospective study to assess the efficacy, safety, and pharmacokinetics of two dose regimens of TP-434 compared with ertapenem in the treatment of adult community-acquired complicated intra-abdominal infections (cIAIs).


Critère d'inclusion

  • Complicated Intra-Abdominal Infection


Liens